Ozempic could be the next target of Medicare drug price negotiations – here’s why

Date:

Wall Street analysts expect Ozempic to be selected for price negotiations in 2025 due to the amount of money Medicare Part D already spends on the drug…

Share post:

Subscribe

Popular

More like this
Related

Alaska Airlines, flight attendants reach ‘record’ tentative labor deal

Alaska's flight attendants' tentative agreement ends a drought of...

DJT share price down nearly 50% since Trump guilty verdict

Trump Media, which trades as DJT, has lost nearly...

Tesla internal data shows company has slashed at least 14% of workforce this year

Tesla internal records viewed by CNBC suggest the company...